Literature DB >> 7849451

11 beta-Hydroxysteroid dehydrogenase: a relevant determinant of gluco- and mineralocorticoid-actions.

F J Frey1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7849451     DOI: 10.1007/bf00212994

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


× No keyword cloud information.
  11 in total

1.  Localization of an 11 beta hydroxysteroid dehydrogenase activity to the distal nephron. Evidence for the existence of two species of dehydrogenase in the rat kidney.

Authors:  W R Mercer; Z S Krozowski
Journal:  Endocrinology       Date:  1992-01       Impact factor: 4.736

2.  Cloning and expression of rat cDNA encoding corticosteroid 11 beta-dehydrogenase.

Authors:  A K Agarwal; C Monder; B Eckstein; P C White
Journal:  J Biol Chem       Date:  1989-11-15       Impact factor: 5.157

3.  Purification and characterization of the corticosteroid 11 beta-dehydrogenase component of the rat liver 11 beta-hydroxysteroid dehydrogenase complex.

Authors:  V Lakshmi; C Monder
Journal:  Endocrinology       Date:  1988-11       Impact factor: 4.736

Review 4.  11 beta-hydroxysteroid dehydrogenase.

Authors:  C Monder; P C White
Journal:  Vitam Horm       Date:  1993       Impact factor: 3.421

Review 5.  Enzymes and receptors: challenges and future directions.

Authors:  J W Funder
Journal:  Steroids       Date:  1994-02       Impact factor: 2.668

6.  Tissue-specific distribution of the NAD(+)-dependent isoform of 11 beta-hydroxysteroid dehydrogenase.

Authors:  B R Walker; J C Campbell; B C Williams; C R Edwards
Journal:  Endocrinology       Date:  1992-08       Impact factor: 4.736

Review 7.  Pharmacology of 11 beta-hydroxysteroid dehydrogenase.

Authors:  F J Frey; G Escher; B M Frey
Journal:  Steroids       Date:  1994-02       Impact factor: 2.668

8.  11 beta-Hydroxysteroid dehydrogenase activity and corticosteroid hormone action.

Authors:  P M Stewart; C B Whorwood
Journal:  Steroids       Date:  1994-02       Impact factor: 2.668

9.  Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle.

Authors:  P M Stewart; J E Corrie; C H Shackleton; C R Edwards
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

10.  Potentiation of hydrocortisone activity in skin by glycyrrhetinic acid.

Authors:  S Teelucksingh; A D Mackie; D Burt; M A McIntyre; L Brett; C R Edwards
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.